Investment Plan

We bring the future into the present, with a 356 million Euro investment plan, which we launched and are already implementing. DEMO is stepping up to become a European and global leader in pharmaceutical manufacture by 2027. Learn more about our investments in pharmaceutical product manufacturing, raw materials, research and development, and biotechnology.

Investment Plan Pillars

Raw materials production

See More

Manufacturing of Finished Products

See More


See More

Research and Development

See More

DEMO’s role in restoring pharmaceutical production in Europe

Why were there significant shortages of medicines and extensive delays in the supply of raw materials in many countries (particularly in Europe) during the pandemic? Which factors prevented Greece from facing such a crisis, and how did DEMO play a key role in this effort?

DEMO SA: “We Bring the Future into the Present” The company announced its 2021-2027 investment plan, worth EUR 356 million.

On Tuesday, November 9, 2021, the CEO of the pharmaceutical industry, Mr. Dimitris Demos, presented the company’s multidimensional investment package…

Read More